The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2028.
A laboratory method that uses antibodies to check for certain antigens (markers) in a sample of tissue. The antibodies are usually linked to an enzyme or a fluorescent dye. IHC has become a crucial technique and is widely applied in the diagnosis of several chronic diseases such as cancer, infectious diseases, and cardiovascular diseases (CVDs).
The rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests are some of the factors that have supported long-term expansion for Immunohistochemistry (IHC) Market.
Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Within a few weeks of research, companies started coming up with drugs and treatments to treat the infection. There has been a tremendous amount of effort put into developing new treatments and vaccines to cure the infection.
North America was the largest regional market for immunohistochemistry market in 2020. APAC is expected to register the fastest growth rate during the forecast period owing to several factors, including increasing disposable income, rising healthcare spending, growing demand for quality medical care, and increasing investments by pharmaceutical and biopharmaceutical companies.
Insights are provided for each region and major countries within the regions
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 2.3 billion |
|
Growth Rate |
CAGR of 7.7% during the forecasting period, 2021-2026 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2026 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2026 |
|
Report Segmentation |
product, application, end user and region |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
F. Hoffman-La Roche AG, Danaher Corporation, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Abcam plc, Becton, Dickinson and Company, PerkinElmer, Inc., Takara Bio, Inc., Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Cell Signaling Technology, Inc., Bio SB, Inc., Miltenyi Biotec, CANDOR Bioscience GmbH, Sakura FinetEK, Japan Co., Ltd., Eagle Biosciences, Inc., BioCare Medical, LLC, Elabscience, Inc., Biogenex Laboratories, Diagnostic Biosystems, Inc., BioVision Inc., Rockland Immunochemicals, Inc., Biotechnologies, Inc. |
|
Available Customization |
In addition to the market data for Immunohistochemistry (IHC) Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Immunohistochemistry (IHC) Market is segmented into product, application, end user and region.
.png)
.png)
.png)
.png)
.png)
.png)